APAC Active Pharmaceutical Ingredients Market Forecast Report to 2028: Featuring Profiles of Key Players AbbVie, Astrazeneca, BASF, GlaxoSmithKline, Novartis, Lupin and Sanofi – ResearchAndMarkets.com


DUBLIN–()–The “APAC Active Pharmaceutical Ingredients Market 2021-2028” report has been added to ResearchAndMarkets.com’s offering.

The Asia Pacific active pharmaceutical ingredients market is forecast to grow by 8.8% annually with a total addressable market cap of $691.3 billion over 2021-2028, driven by rising adoption of biologics in disease management, increasing regulatory approvals, patent expiration of major drugs, growing trend of outsourcing and increase in geriatric population.

The report is based on comprehensive research of the entire Asia Pacific active pharmaceutical ingredients market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2028 with 2021 as the base year.

In-depth qualitative analyses include identification and investigation of the following aspects:

  • Market Structure
  • Growth Drivers
  • Restraints and Challenges
  • Emerging Product Trends & Market Opportunities
  • Porter’s Five Forces

The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific active pharmaceutical ingredients market in every aspect of the classification from perspectives of Synthesis, Manufacturing Process, Therapeutic Application, Drug Type, and Country.

Based on Synthesis, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ bn) for 2018-2028 included in each section.

Synthetic API

  • Branded Synthetic API
  • Generic Synthetic API

Biotech API by Drug Type:

  • Monoclonal Antibodies
  • Recombinant Proteins
  • Vaccines
  • Other Biotech APIs

Biotech API by Customer Base:

  • Innovative Biologic API
  • Generic Biosimilar API

Biotech API by Expression Technology:

  • Mammalian Expression
  • Microbial Expression
  • Yeast Expression
  • Insect Expression
  • Other Expression Technologies

HPAPI

  • Branded HPAPI
  • Generic HPAPI

Based on Manufacturing Process, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ bn) for 2018-2028 included in each section.

Captive Manufactur ing

  • Branded Captive API
  • Generic Captive API

Merchant Manufacturing by Drug Type:

  • Branded Merchant API
  • Generic Merchant API

Merchant Manufacturing by Drug Synthesis:

  • Merchant Synthetic API
  • Merchant Biotech API

By Therapeutic Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ bn) for 2018-2028 included in each section.

  • Infectious Diseases
  • Oncology
  • Ophthalmology
  • Cardiovascular Disorders
  • Central Nervous System
  • Pulmonary Disorders
  • Orthopedics
  • Other Applications

By Drug Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ bn) for 2018-2028 included in each section.

  • Branded Prescription Drugs
  • Generic Prescription Drugs
  • OTC Drugs

Geographically, the following national/local markets are fully investigated:UK

  • Japan
  • China
  • South Korea
  • Australia
  • India
  • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)

For each key country, detailed analysis and data for annual revenue ($ bn) are available for 2018-2028. The breakdown of key national markets by Synthesis, Manufacturing Process, and Therapeutic Application, over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

  • AbbVie Inc.
  • Astrazeneca
  • Aurobindo Pharma Ltd.
  • BASF
  • Bayer AG
  • Boehringer Ingelheim
  • Catalent Inc.
  • Dr. Reddy’s Laboratories
  • F. Hoffmann-La Roche
  • GlaxoSmithKline plc
  • Lonza Group
  • Lupin Limited
  • Merck & Co., Inc.
  • Mylan NV
  • Novartis International AG
  • Pfizer Inc.
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Thermo Fisher Scientific

For more information about this report visit https://www.researchandmarkets.com/r/o2bdtk

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.



Source link

The content is by Business Wire. Headlines of Today Media is not responsible for the content provided or any links related to this content. Headlines of Today Media is not responsible for the correctness, topicality or the quality of the content.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy